Dorte L. Nielsen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 188 publications

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Journal: Journal for immunotherapy of cancer

Published: June 29, 2026

Corrigendum to "Study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay)" [Eur. J. Oncol. Nurs. 76C [2025] 102898].

Corrigendum to "Study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay)" [Eur. J. Oncol. Nurs. 76C [2025] 102898].

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: February 05, 2026

Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis.

Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: January 03, 2026

Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 23, 2025

Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis.

Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis.

Journal: Cancer treatment reviews

Published: June 19, 2025

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

Journal: BMC cancer

Published: June 15, 2025

Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 12, 2025

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study.

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study.

Journal: Cardio-oncology (London, England)

Published: April 24, 2025

A study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay).

A study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay).

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: March 01, 2025

Incidence of myocardial ischemia during treatment with capecitabine: a cohort study with Holter recording and cardiac biomarkers.

Incidence of myocardial ischemia during treatment with capecitabine: a cohort study with Holter recording and cardiac biomarkers.

Journal: Acta oncologica (Stockholm, Sweden)

Published: February 03, 2025

Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients.

Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients.

Journal: The oncologist

Published: December 14, 2024

The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancer.

The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancer.

Journal: Cancer treatment and research communications

Published: November 30, 2024

Showing 1-12 of 188

Last Updated: 09/26/2026